are these expenses justified ???who is the audience here? Customers? Financiers??? I don't think we need exposure here (except IF the financiers are walking off and we need a new set of bankers)...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
